Cargando…

A Dynamic Mathematical Modeling Revelation about the Impact of Vaccination on Hepatitis B Virus-induced Infection and Death Rate in Bangladesh

AIM: Attainment of sustainable development goal (SDG) targets requires reducing the rate of new hepatitis B virus (HBV)-induced infection and mortality rate to 90% and 65%, respectively, by 2030. Therefore, it is important to investigate the feasibility of reducing the required rates of HBV-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chakraborty, Sajib, Chakravorty, Rajib, Alam, Saruar, Kabir, Yearul, Mahtab, Musarrat, Islam, Md Atikul, Yusuf, Md Abul Khair, Raihan, Ruksana, Al Mahtab, Mamun, Akbar, Sheikh Mohammad Fazle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Jaypee Brothers Medical Publishers 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7047315/ https://www.ncbi.nlm.nih.gov/pubmed/32117696 http://dx.doi.org/10.5005/jp-journals-10018-1303

Ejemplares similares

Therapy Targeting Stem Cell in Patients with Decompensated Cirrhosis of Liver in a Tertiary Treatment Care Center of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

Genomic analysis of Hepatitis B virus and its association with disease manifestations in Bangladesh
por: Raihan, Ruksana, et al.
Publicado: (2019)

Treatment of COVID-19 Patients at a Medical College Hospital in Bangladesh
por: Bhuyan, Muhammad AR, et al.
Publicado: (2020)

Plasma Exchange in Patients of Acute on Chronic Liver Failure: An Observational Study in Bangladesh
por: Mukit, Abdullah Al, et al.
Publicado: (2022)

Alarming Levels of Hepatitis C Virus Prevalence among Rohingya Refugees in Bangladesh: Emergency National and International Actions Warranted
por: Mahtab, Mamun Al, et al.
Publicado: (2019)

Healthcare for non-Covid-19 liver disease patients during the Covid-19 pandemic in Bangladesh: Current trend and future implications
por: Faizul Huq, A. K. M., et al.
Publicado: (2020)

Therapeutic Endoscopy during COVID-19 Pandemic: An Observational Study from Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2020)

Clinical Manifestations of Hospitalized COVID-19 Patients in Bangladesh: A 14-day Observational Study
por: Shaha, Modhusudon, et al.
Publicado: (2021)

Tele-education for hepatology residents in Bangladesh during the Covid-19 pandemic
por: Mahtab, Mamun A., et al.
Publicado: (2020)

EDITORIAL
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2019)

Real-life Management Strategy of COVID-19 Patients in Bangladesh with No Death: An Observational and Cohort Study
por: Faizul Huq, AKM, et al.
Publicado: (2020)

Recent downhill course of COVID-19 at Rohingya refugee camps in Bangladesh: Urgent action solicited
por: Khan, Sakirul, et al.
Publicado: (2021)

The Journal in the Horizon of Asia and Europe
por: Fazle Akbar, Sheikh Mohammad, et al.
Publicado: (2018)

Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

An Outbreak of Acute Hepatitis in a Medical Facility of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2014)

Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure
por: Malakar, Debraj, et al.
Publicado: (2021)

A high-throughput test enables specific detection of hepatocellular carcinoma
por: Cheishvili, David, et al.
Publicado: (2023)

High Prevalence of Wilson's Diseases with Low Prevalence of Kayser–Fleischer Rings among Patients with Cryptogenic Chronic Liver Diseases in Bangladesh
por: Choudhury, Nuzhat, et al.
Publicado: (2019)

A Case of Antimitochondrial Antibody Negative Primary Biliary Cirrhosis from Bangladesh and Review of Literature
por: Begum, Roksana, et al.
Publicado: (2015)

Extraordinary Survival Benefits of Severe and Critical Patients with COVID-19 by Immune Modulators: The Outcome of a Clinical Trial in Bangladesh
por: Islam, Md Azizul, et al.
Publicado: (2020)

Elimination of Hepatitis Viruses: Bangladesh Scenario
por: Al Mahtab, Mamun
Publicado: (2017)

Stem Cell Therapy for Cirrhosis of Liver in Bangladesh: Specific Design Compatible for Developing Country
por: Al Mahtab, Mamun, et al.
Publicado: (2018)

Hepatitis B Core Antigen in Hepatocytes of Chronic Hepatitis B: Comparison between Indirect Immunofluorescence and Immunoperoxidase Method
por: Raihan, ,Ruksana, et al.
Publicado: (2015)

Epidemiology of Viral Hepatitis and Liver Diseases in Bangladesh
por: Mahtab, Mamun-Al
Publicado: (2015)

Past, Present, and Future of Viral Hepatitis in Bangladesh
por: Mamun-Al-Mahtab,
Publicado: (2016)

Risk of congenital birth defects during COVID-19 pandemic: Draw attention to the physicians and policymakers
por: Khan, Md Sakirul Islam, et al.
Publicado: (2020)

Epidemiology of Hepatitis E Virus in an Urban Community in Dhaka City
por: Rahman, Salimur, et al.
Publicado: (2014)

Development of Therapeutic Vaccine for Chronic Hepatitis B: Concept, Cellular and Molecular Events, Design, Limitation, and Future Projection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Treatment by Transarterial Chemoembolization and Sorafenib for Hepatocellular Carcinoma vs Advanced Hepatocellular Carcinoma in Bangladesh: A Real-life Situation
por: Al Mahtab, Mamun, et al.
Publicado: (2019)

Characterization of the Protective HIV-1 CTL Epitopes and the Corresponding HLA Class I Alleles: A Step towards Designing CTL Based HIV-1 Vaccine
por: Chakraborty, Sajib, et al.
Publicado: (2014)

Observational study on the response of tenofovir monotherapy versus tenofovir plus telbivudine dual therapy in patients with hepatitis B virus related acute on chronic liver failure
por: Manik, Abul H, et al.
Publicado: (2021)

Unprecedented rise of monkeypox in Europe and America: Are Asian countries ready for a new outbreak during the ongoing COVID-19 pandemic?
por: Khan, Sakirul, et al.
Publicado: (2022)

Prevalence of Hepatitis B Virus and Hepatitis C Virus in a Tea Garden of Bangladesh
por: Al Mahtab, Mamun, et al.
Publicado: (2017)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19
por: Khan, Md. Saiful Islam, et al.
Publicado: (2020)

Nobel Prize for the Discovery of Hepatitis B and C: A Brief History in Time
por: Al-Mahtab, Mamun, et al.
Publicado: (2020)

Antiviral Response across Genotypes after Treatment of Chronic Hepatitis B Patients with the Therapeutic Vaccine NASVAC or Pegylated Interferon
por: Al-Mahtab, Mamun, et al.
Publicado: (2023)

Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2023)

Developing a Cold-Related Mortality Database in Bangladesh
por: Alam, Md. Mahbub, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kpcusj8hl4mkjef4oheb2ed71r